Growing Antitrust Scrutiny of Healthcare Mergers: What Healthcare Executives Need to Know

By Katharine O’Connor on October 5, 2022

How can healthcare executives navigate the growing antitrust scrutiny of healthcare mergers, and what are some of the key issues facing executives in the current regulatory environment? In this conversation with The Chartis Group, McDermott Partner Katharine O’Connor discusses the legal considerations for healthcare executives seeking to navigate mergers.

Access the article.

Tags: antitrust, Federal Trade Commission (FTC), healthcare

Katharine O’Connor
Katharine (Kate) O’Connor focuses her practice on complex antitrust litigation, antitrust investigations brought by the US antitrust regulators and state attorneys general, and counseling clients on antitrust compliance questions. Kate also regularly represents clients before the antitrust regulators related to mergers and acquisitions. Kate has experience representing clients in a wide array of industries, including healthcare, manufacturing, food and finance. Kate is a member of the firm’s antitrust and competition practice, which Global Competition Review has designated a “Global Elite” and “Illinois Elite” practice. She has been recognized by Global Competition Review, Benchmark Litigation, Legal 500 US and Super Lawyers as excelling in the field of antitrust. Read Katharine O’Connor's full bio.

Growing Antitrust Scrutiny of Healthcare Mergers: What Healthcare Executives Need to Know

Related Posts

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

RECENT POSTS